RLS-0071 for newborns with moderate or severe HIE
Part of Brain & nervous system, Genetic & congenital, Heart & circulation clinical trials.
This trial studies whether RLS-0071 is safe and can help some newborns with moderate or severe hypoxic-ischemic encephalopathy (HIE), a brain injury caused by low oxygen around birth. Babies in the study also receive standard whole-body cooling (therapeutic hypothermia), and the researchers will watch for side effects and early signs of benefit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Born at 36 weeks or later (not extremely premature).
- Had a serious birth event or sudden fetal status change right before/during delivery that could explain the newborn’s poor condition.
- Meet criteria for moderate or severe HIE, such as very abnormal early blood tests, a very low 10-minute Apgar score, needing breathing help for at least 10 minutes, and/or seizures.
- Must be able to start whole-body cooling before 6 hours of age (passive cooling is allowed first).
- Pregnancy was a single baby (not twins or more).
- Parent/legal guardian can sign consent, and the baby can start the first dose within 10 hours of life.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for newborn babies who had an oxygen shortage around birth and now have severe brain injury. It aims to test approaches that may help improve outcomes after this kind of early-life brain damage.
This study looks at a special blood marker in full-term newborns who had brain injury from lack of oxygen during birth. It aims to help doctors better understand and treat this condition.
This trial tests whether adding sildenafil to standard cooling treatment helps newborns who had a lack of oxygen to the brain. It aims to see if this combination can reduce brain damage and improve outcomes.
This study looks at whether a computer can read a baby's brain-wave test (EEG) to help doctors predict outcomes after oxygen loss at birth. If it works, it could help guide treatment decisions.
This early study tests whether giving melatonin to newborns with hypoxic-ischemic encephalopathy (brain injury from not enough oxygen around birth) can help protect the brain while they are cooled (therapeutic hypothermia). It may be most relevant if your baby shows early brain-injury signs and meets specific blood test and birth-history timing criteria.
This study uses whole genome sequencing to look at the genes of newborns with HIE (brain injury from lack of oxygen) who are receiving cooling treatment. The goal is to learn more about how genes may affect recovery and outcomes.
Hear when a new Hypoxic-Ischemic Encephalopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.